24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULF...

Por Lipson, David A., Birk, Ruby, Brealey, Noushin, Zhu, Chang-Qing
Publicado no Adv Ther (2020)

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

Por Mehta, Rashmi, Farrell, Colm, Hayes, Siobhán, Birk, Ruby, Okour, Malek, Lipson, David A.
Publicado no Clin Pharmacokinet (2019)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a r...

Por Bremner, Peter R., Birk, Ruby, Brealey, Noushin, Ismaila, Afisi S., Zhu, Chang-Qing, Lipson, David A.
Publicado no Respir Res (2018)

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD

Por Mehta, Rashmi, Pefani, Eleni, Beerahee, Misba, Brealey, Noushin, Barnacle, Helen, Birk, Ruby, Zhu, Chang‐Qing, Lipson, David A.
Publicado no J Clin Pharmacol (2018)

Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life

Por Tabberer, Maggie, Lomas, David A., Birk, Ruby, Brealey, Noushin, Zhu, Chang-Qing, Pascoe, Steve, Locantore, Nicholas, Lipson, David A.
Publicado no Adv Ther (2018)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD

Por Naya, Ian, Compton, Chris, Ismaila, Afisi S., Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A., Criner, Gerard
Publicado no ERJ Open Res (2018)

Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial

Por Ismaila, Afisi S., Birk, Ruby, Shah, Dhvani, Zhang, Shiyuan, Brealey, Noushin, Risebrough, Nancy A., Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A.
Publicado no Adv Ther (2017)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses

Por Halpin, David M.G., Birk, Ruby, Brealey, Noushin, Criner, Gerard J., Dransfield, Mark T., Hilton, Emma, Lomas, David A., Zhu, Chang-Qing, Lipson, David A.
Publicado no ERJ Open Res (2018)